Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
125.1 EUR | -0.37% |
|
-4.81% | -8.55% |
Jul. 02 | Citigroup Downgrades D.R. Horton to Neutral From Buy, Adjusts Price Target to $156 From $181 | MT |
Jul. 01 | Inventory, Affordability Challenges May Weigh on New Home Sales, Wedbush Says | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's attractive earnings multiples are brought to light by a P/E ratio at 9.54 for the current year.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Homebuilding
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-8.55% | 44.64B | - | ||
+0.71% | 21.87B | C- | ||
-3.77% | 16.37B | B+ | ||
+6.20% | 11.21B | C+ | ||
+4.05% | 6.94B | B+ | ||
+26.74% | 6.78B | A- | ||
+2.94% | 6.53B | B | ||
-10.42% | 6.26B | C+ | ||
+5.40% | 5.99B | C+ | ||
+8.31% | 5.72B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- DHI Stock
- HO2 Stock
- Ratings DR Horton